These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 10488961)
1. Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes. Varu VN; Ahanchi SS; Hogg ME; Bhikhapurwala HA; Chen A; Popowich DA; Vavra AK; Martinez J; Jiang Q; Saavedra JE; Hrabie JA; Keefer LK; Kibbe MR Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H772-9. PubMed ID: 20562340 [TBL] [Abstract][Full Text] [Related]
2. Atlas of Cell Repertoire Within Neointimal Lesions Is Metabolically Altered in Hypertensive Rats. Sun X; Wu J; Zhang X; Xie C; Wei H; Li P; Yang Y; Yuan H; Cai J; Xiao Q; Cheng J; Xu Q Hypertension; 2024 Apr; 81(4):787-800. PubMed ID: 38240164 [TBL] [Abstract][Full Text] [Related]
3. Effects of PPAR γ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats. Dovinová I; Barancik M; Majzunova M; Zorad S; Gajdosechová L; Gresová L; Cacanyiova S; Kristek F; Balis P; Chan JY PPAR Res; 2013; 2013():541871. PubMed ID: 24454335 [TBL] [Abstract][Full Text] [Related]
4. Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and proliferation. Cersosimo E; Xu X; Upala S; Triplitt C; Musi N Physiol Rep; 2014 Aug; 2(8):. PubMed ID: 25138792 [TBL] [Abstract][Full Text] [Related]
5. Trans-repression of NFκB pathway mediated by PPARγ improves vascular endothelium insulin resistance. Kong Y; Gao Y; Lan D; Zhang Y; Zhan R; Liu M; Zhu Z; Zeng G; Huang Q J Cell Mol Med; 2019 Jan; 23(1):216-226. PubMed ID: 30398029 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase. Osman I; Fairaq A; Segar L Pharmacology; 2017; 100(1-2):64-73. PubMed ID: 28482342 [TBL] [Abstract][Full Text] [Related]
7. Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways. Kubota T; Kubota N; Sato H; Inoue M; Kumagai H; Iwamura T; Takamoto I; Kobayashi T; Moroi M; Terauchi Y; Tobe K; Ueki K; Kadowaki T Sci Rep; 2016 Oct; 6():34707. PubMed ID: 27703271 [TBL] [Abstract][Full Text] [Related]
8. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling. Osman I; Segar L Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070 [TBL] [Abstract][Full Text] [Related]
9. PPARgamma and its ligands: therapeutic implications in cardiovascular disease. Villacorta L; Schopfer FJ; Zhang J; Freeman BA; Chen YE Clin Sci (Lond); 2009 Feb; 116(3):205-18. PubMed ID: 19118492 [TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice. Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases. Gizard F; Bruemmer D PPAR Res; 2008; 2008():429123. PubMed ID: 18288288 [TBL] [Abstract][Full Text] [Related]
12. The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis. Verma S; Szmitko PE Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):12B-17B. PubMed ID: 16498507 [TBL] [Abstract][Full Text] [Related]
13. Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting? Blaschke F; Bruemmer D; Law RE Clin Cardiol; 2004 Jul; 27(7 Suppl 4):IV3-10. PubMed ID: 15470905 [TBL] [Abstract][Full Text] [Related]
14. The role of sulphonylureas in the management of type 2 diabetes mellitus. Rendell M Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348 [TBL] [Abstract][Full Text] [Related]
15. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259 [TBL] [Abstract][Full Text] [Related]
16. Metabolic and additional vascular effects of thiazolidinediones. Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315 [TBL] [Abstract][Full Text] [Related]